Cited by 665Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease

Open access

Fichtlscherer, Stephan, Rosenberger, Gunter, Walter, Dirk H., Breuer, Susanne, Dimmeler, Stefanie, Zeiher, Andreas M.·2000·Circulation

DOI 10.1161/01.cir.102.9.1000

Open this paper in CoChat — free account Open PDF

Abstract

Background —Elevated C-reactive protein (CRP) serum levels, an exquisitely sensitive objective marker of inflammation, relate to long-term prognosis in patients with coronary artery disease and in apparently healthy men. Because abnormalities of endothelial regulation of vascular function may contribute to the occurrence of coronary events, we tested the hypothesis that elevated CRP levels are associated with an abnormal systemic endothelial vascular reactivity. Methods and Results —Endothelium-dependent (10 to 50 μg/min acetylcholine) and endothelium-independent (2 to 8 μg/min sodium nitroprusside) forearm blood flow responses were measured with venous occlusion plethysmography in 60 male patients with angiographically documented coronary artery disease. Forearm blood flow responses to acetylcholine were inversely correlated with CRP serum levels ( r =−0.46, P =0.001). With multivariate analysis that included the classic risk factors for coronary artery disease, elevated CRP serum level remained a statistically significant independent predictor of a blunted endothelial vasodilator capacity. Most important, normalization of elevated CRP levels over time was associated with a normalization of endothelium-mediated forearm blood flow responses after 3 months. Conclusions —Thus, elevated CRP serum levels indicative of a systemic inflammatory response are associated with a blunted systemic endothelial vasodilator function. The identification of elevated CRP levels as a transient independent risk factor for endothelial dysfunction might provide an important clue to link a systemic marker of inflammation to atherosclerotic disease progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.102.9.1000

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Analysis of serial measurements in medical research.
Matthews, J. N. S., Altman, D. G., Campbell, M. J., & Royston, P. J. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,137
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,885
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511
The measurement of volume changes in human limbs
Whitney, R. J. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004926 · Cited by 1,496
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 994
Self-citation
C-Reactive Protein as a Cardiovascular Risk Factor
Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833

Show all 25 references

Research works printed but not linked: 9

10.1161/circ.96.11.4095 · DOI
10.1161/circ.94.5.874 · DOI
10.1161/hyp.25.2.155 · DOI
10.1161/hyp.25.5.918 · DOI
10.1161/circ.95.9.2293 · DOI
10.1161/circ.83.2.1991363 · DOI
10.1161/circ.88.6.8080489 · DOI
10.1161/circ.99.2.237 · DOI
10.1161/circ.100.11.1148 · DOI

Sorted by citations

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
“Elevated CRP levels have been similarly associated with blunted endothelial vasoreactivity and, perhaps more importantly, CRP normalization is associated with subsequent improvement of regional blood flow.(47) In addition, crosssectional analyses show that CRP is Figure 2.”
Background
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Air Pollution and Cardiovascular Disease
Brook, R. D., Franklin, B. A., Cascio, W. E., Hong, Y., Howard, G., D, M. L. M., Luepker, R. V., Mittleman, M. A., Samet, J. M., Smith, S. C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128587.30041.c8 · Cited by 2,454
Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
“mation, including increased levels of C-reactive protein (7), are also associated with endothelial dysfunction in human subjects (8,42,43).”
Background
High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits‐Filho, R., RIELLA, M. C., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 952
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells
Venugopal, S. K., Devaraj, S., Yuhanna, I. S., Shaul, P. W., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 849
Endothelial Function: A Critical Determinant in Atherosclerosis?
Landmesser, U., Hornig, B., & Drexler, H. (2004) · Circulation · doi:10.1161/01.cir.0000129501.88485.1f · Cited by 851
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
Hadi, H. A. R., Carr, C. S., & Suwaidi, J. M. S. A. (2005) · PubMed Central · Cited by 807
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 756
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 635
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 574
Endothelial Function Testing as a Biomarker of Vascular Disease
Verma, S., Buchanan, M. R., & Anderson, T. J. (2003) · Circulation · doi:10.1161/01.cir.0000089191.72957.ed · Cited by 575
High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease
Rifai, N., & Ridker, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.403 · Cited by 518
“Finally, physical exercise has been shown to have a beneficial effect in terms of reducing the concentration of several inflammatory markers (47, 48 ). Taken together, the available evidence thus supports the hypothesis that hs-CRP concentrations correlate with endothelial dysfunction ( 49 ).”
Result
Endothelial dysfunction: a comprehensive appraisal.
Esper, R. J., Nordaby, R. A., Vilariño, J. O., Paragano, A. J., Cacharrón, J. L., & Machado, R. A. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-4 · Cited by 508
Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013)
JCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0098 · Cited by 462
Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease
Shoji, T., Emoto, M., Shinohara, K., Kakiya, R., TSUJIMOTO, Y., Kishimoto, H., Ishimura, E., Tabata, T., & Nishizawà, Y. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102117 · Cited by 450
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Salvetti, A., Ferrannini, E., & Monzani, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030039 · Cited by 431
“In this regard, all the patients had thyroiditis; and therefore, a possible concomitant effect of inflammation and autoimmunity should be not overlooked, because inflammatory states are associated with endothelial dysfunction (35).”
Background
C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals
Yasmin, Y., McEniery, C. M., Wallace, S. M. L., Mackenzie, I. S., Cockcroft, J. R., & Wilkinson, I. B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.zhq0504.0173 · Cited by 400
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 369
Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation
Amar, S., Gokce, N., Morgan, S., Loukideli, M., Van Dyke, T. E., & Vita, J. A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000078603.90302.4a · Cited by 361
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L. E., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 356
Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension
Mahmud, A., & Feely, J. (2005) · Hypertension · doi:10.1161/01.hyp.0000185463.27209.b0 · Cited by 345
Endothelial dysfunction over the course of coronary artery disease
Gutiérrez, E., Flammer, A. J., Lerman, L. O., Elı́zaga, J., Lerman, A., & Fernández‐Avilés, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht351 · Cited by 334
“In patients with unstable angina, endothelium-dependent vasoreactivity parallels inflammatory activity as expressed by C-reactive protein levels.(66) Figure 3 Illustration of the post-stent epicardial reactivity to acetylcholine in the various studies referenced in the text(56) .”
Background
Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children
Järvisalo, M. J., Harmoinen, A. P. T., Hakanen, M., Paakkunainen, U., Viikari, J. S. A., Hartiala, J., Lehtimäki, T. J., Simell, O., & Raitakari, O. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024222.06463.21 · Cited by 317
Human CRP Gene Polymorphism Influences CRP Levels
Brull, D. J., Serrano, N. C., Zito, F., Jones, L., Montgomery, H., Rumley, A., Sharma, P. K., Lowe, G. D. O., WORLD, M. J., Humphries, S. E., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000084640.21712.9c · Cited by 304
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302
Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation
Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 298
Human C-reactive protein and the metabolic syndrome
Devaraj, S., Singh, U. S., & Jialal, I. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ac03e · Cited by 295
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 290
C-Reactive Protein and Glycemic Control in Adults With Diabetes
King, D. E., Mainous, A. G., Buchanan, T. A., & Pearson, W. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1535 · Cited by 281
“Other studies have related hyperglycemia to inflammation by demonstrating simultaneous inflammation, endothelial dysfunction, and insulin resistance at the physiologic level (23,24).”
Background
The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes
Ray, K. K., & Cannon, C. P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.086 · Cited by 276
Statins and sepsis: multiple modifications at multiple levels.
Terblanche, M., Almog, Y., Rosenson, R., Smith, T. S., & Hackam, D. (2007) · Lancet. Infectious Diseases (Print) · doi:10.1016/s1473-3099(07)70111-1 · Cited by 291
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Clinical Application of Noninvasive Vascular Ultrasound in Cardiovascular Risk Stratification: A Report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology
Roman, M. J., Naqvi, T. Z., Gardin, J. M., Gerhard‐Herman, M. D., Jaff, M. R., & Mohler, E. R. (2006) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2006.04.020 · Cited by 260
Endothelial function, inflammation, and prognosis in cardiovascular disease
Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 263
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
McDermott, D. H., Halcox, J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 260
Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes
Fichtlscherer, S., Breuer, S., & Zeiher, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000143378.58099.8c · Cited by 251
“Antidiabetics/insulin 8 (5)/7 (4) 1 (3)/4 (13) NS”
Self-citation
C-reactive protein and cardiovascular disease: new insights from an old molecule
Hirschfield, G. M., & Pepys, M. B. (2003) · QJM · doi:10.1093/qjmed/hcg134 · Cited by 256
Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2008)
JCS Joint Working Group (2010) · Circulation Journal · doi:10.1253/circj.cj-10-74-0802 · Cited by 251
Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease
Kuvin, J. T., Patel, A. R., Sliney, K. A., Pandian, N. G., Rand, W. M., Udelson, J. E., & Karas, R. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01657-6 · Cited by 249
Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults
Brook, R. D., Bard, R. L., Rubenfire, M., Ridker, P. M., & Rajagopalan, S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02088-4 · Cited by 246
Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans
Donato, A. J., Black, A. D., Jablonski, K. L., Gano, L. B., & Seals, D. R. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00438.x · Cited by 237
The Evolving Role of C-Reactive Protein in Atherothrombosis
Devaraj, S., Singh, U. S., & Jialal, I. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108886 · Cited by 236
Correlation between cardiovascular disease and diabetes mellitus: current concepts
Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 238
Effects of intranasal 17β-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women
Rachoń, D., Suchecka-Rachoń, K., Hak, Ł., & Myśliwska, J. M. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000227400.60816.52 · Cited by 230
“678 Serum E2 (pmol/L) 47 (33-102) 69 (14-112) 71 (26-96) 0.”
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study
Folsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 227
The Role of Inflammation in the Pathogenesis of Glaucoma
Vohra, R., Tsai, J. C., & Kolko, M. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.010 · Cited by 214
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198
“Proposed mechanisms through which low-grade inflammation might influence atherogenesis include accelerated foam cell formation by monocyte recruitment and native low-density lipoprotein cholesterol (LDL-c) uptake in the arterial wall [11, 12] Elevated CRP levels are also associated with blunted systemic endothelial va…”
Background
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians
Weyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 214
Endothelial Dysfunction in Obstructive Sleep Apnea
Budhiraja, R., Parthasarathy, S., & Quan, S. F. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26864 · Cited by 208
Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study
Vita, J. A., Keaney, J. F., Larson, M. G., Keyes, M. J., Massaro, J. M., Lipinska, I., Lehman, B. T., Fan, S., Osypiuk, E. W., Wilson, P. W. F., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148821.97162.5e · Cited by 204
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
Chan, A. W., Bhatt, D. L., Chew, D. P., Reginelli, J. P., Schneider, J. P., Topol, E. J., & Ellis, S. G. (2003) · Circulation · doi:10.1161/01.cir.0000060541.18923.e9 · Cited by 207
Effects of Changes in Body Weight and Insulin Resistance on Inflammation and Endothelial Function in Morbid Obesity after Bariatric Surgery
Vázquez, L. A., Pazos, F., de Berrazueta, J. R., Fernández-Escalante, C., García‐Unzueta, M. T., Freijanes, J., & Amado, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032059 · Cited by 205
“Finally, because the possible correlation between venous and arterial dysfunction remains to be demonstrated in morbid obesity, discrepancies with previous reports in the associations between inflammatory markers and vasodilatory response (49, 50) may be related to different study protocols, i.”
Result
Periodontal Therapy Reduces Plasma Levels of Interleukin‐6, C‐Reactive Protein, and Fibrinogen in Patients With Severe Periodontitis and Refractory Arterial Hypertension
Vidal, F., Figueredo, C. M., Cordovil, I., & Fischer, R. G. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080471 · Cited by 204
Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013):– Digest Version –
JCSJointWorkingGroup (2014) · Circulation · Cited by 200
Low-Grade Systemic Inflammation Causes Endothelial Dysfunction in Patients with Hashimoto’s Thyroiditis
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., Ghiadoni, L., Ferrannini, E., Salvetti, A., & Monzani, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1075 · Cited by 196
Endothelial function and inflammation in coronary artery disease
Tousoulis, D., Charakida, M., & Stefanadis, C. (2005) · Postgraduate Medical Journal · doi:10.1136/hrt.2005.066936 · Cited by 195
Inflammation and Atherosclerosis
Jialal, I., & Devaraj, S. (2001) · Pathology Patterns Reviews · doi:10.1309/j63v-5lth-wyfc-vdr5 · Cited by 195
The Verdict Is Still Out
Scirica, B. M., & Morrow, D. A. (2006) · Circulation · doi:10.1161/circulationaha.105.611350 · Cited by 189
High-Sensitivity C-Reactive Protein and Coronary Heart Disease Mortality in Patients With Type 2 Diabetes
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells
Venugopal, S. K., Devaraj, S., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000094736.10595.a1 · Cited by 184
Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes
Yiu, Y.-F., Yiu, K., Siu, C., Chan, Y., Li, S.-W., Wong, L.-Y., Lee, S. W. L., Tam, S., Wong, E. W. K., Lau, C., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.013 · Cited by 186
Inflammation and Endothelial Function
Clapp, B. R., Hirschfield, G. M., Storry, C., Gallimore, J. R., Stidwill, R. P., Singer, M., Deanfield, J. E., MacAllister, R. J., Pepys, M. B., Vallance, P. J., et al. (2005) · Circulation · doi:10.1161/01.cir.0000159336.31613.31 · Cited by 181
Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo
Hein, T. W., Singh, U. S., Vasquez-Vivar, J. M., Devaraj, S., Kuo, L., & Jialal, I. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.002 · Cited by 176
Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation
Silva, I. V. G., de Figueiredo, R. C., & Rios, D. R. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143458 · Cited by 184
“First- or second-generation β-blockers do not appear to improve arterial stiffness, inflammatory cytokine expression, NO-dependent vasodilation, or oxidative stress in patients with hypertension [21,40,73].”
Background
Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function
Hall, W. L. (2009) · Nutrition Research Reviews · doi:10.1017/s095442240925846x · Cited by 168
“Another method involves venous occlusion plethysmography to measure forearm blood flow in peripheral resistance vessels following infusion of acetylcholine((10)).”
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden
Brevetti, G., Silvestro, A., Giacomo, S. D., Bucur, R., Donato, A. D., Schiano, V., & Scopacasa, F. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00124-1 · Cited by 165
“Age (y) 62 8 65 10 Sex (M/F) 27/3 81/7 Hypertension 6 (20) 48 (55)* Systolic BP (mm Hg) 136 11 145 18* Diastolic BP (mm Hg) 80 7 82 10 Smoking status Current 5 (17) 46 (52)* Former 10 (33) 35 (40) Hyperlipidemia 4 (13) 48 (55)* Cholesterolemia (mg/dL) 221 48 217 46 HDL-cholesterol (mg/dL) 43 8 41 9 Triglyceride level…”
C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms
Cosı́n-Sales, J., Pizzi, C., Brown, S., & Kaski, J. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00243-2 · Cited by 165
C-Reactive Protein Enhances LOX-1 Expression in Human Aortic Endothelial Cells
Li, L., Roumeliotis, N., Sawamura, T., & Renier, G. (2004) · Circulation Research · doi:10.1161/01.res.0000147309.54227.42 · Cited by 160
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
de Ferranti, S. D., & Rifai, N. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00797-5 · Cited by 162
Adaptive changes in autogenous vein grafts for arterial reconstruction: Clinical implications
Owens, C. D. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.07.102 · Cited by 157
“[95][96][97] Further, in a cohort of patients undergoing vascular surgery, impaired FMD has been shown to be independently associated with adverse 30-day cardiovascular outcomes.”
Background
Endothelial Dysfunction, Vascular Disease and Stroke: The ARTICO Study
Roquer, J., Segura, T., Serena, J. L., & Castillo, J. (2009) · Cerebrovascular Diseases · doi:10.1159/000200439 · Cited by 156
Macrophage Conditioned Medium Induces the Expression of C-Reactive Protein in Human Aortic Endothelial Cells
Venugopal, S. K., Devaraj, S., & Jialal, I. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62345-0 · Cited by 156
Accelerated atherogenesis in autoimmune rheumatic diseases
Bacon, P. A., Stevens, R. J., Carruthers, D. M., Young, S. P., & Kitas, G. D. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00100-3 · Cited by 155
Effect of Nifedipine and Cerivastatin on Coronary Endothelial Function in Patients With Coronary Artery Disease
The ENCORE Investigators (2003) · Circulation · doi:10.1161/01.cir.0000046488.52939.bf · Cited by 153
Health Effects of Particulate Matter
Myong, J. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.91.2.106 · Cited by 152
“연쇄적인 증가(fibrinogen [37], IL-6농도[38], CRP [39,40])를”
C-reactive protein and arterial stiffness in older adults: the Rotterdam Study
Mattace-Raso, F. U. S., van der Cammen, T. J. M., van der Meer, I. M., Schalekamp, M. A. D. H., Asmar, R. G., Albert Hofman, D., & Witteman, J. C. M. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.014 · Cited by 149
Tumor Necrosis Factor Antagonism With Etanercept Improves Systemic Endothelial Vasoreactivity in Patients With Advanced Heart Failure
Fichtlscherer, S., Rössig, L., Breuer, S., Vasa‐Nicotera, M., Dimmeler, S., & Zeiher, A. M. (2001) · Circulation · doi:10.1161/hc5001.101749 · Cited by 147
Self-citation
A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia
Qiu, C. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.011 · Cited by 145
Clinical Utility of Endothelial Function Testing
Kuvin, J. T., & Karas, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000075928.54461.33 · Cited by 143
Clopidogrel Improves Systemic Endothelial Nitric Oxide Bioavailability in Patients With Coronary Artery Disease
Heitzer, T. A., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R. H., & Baldus, S. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225288.74170.dc · Cited by 141
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women
Yavuz, D. G., Deyneli, O., Akpınar, İ., Yildiz, E., Gözü, H. I., Sezgin, O., Haklar, G., & Akalın, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490187 · Cited by 141
“Low-grade chronic inflammation, characterized by elevated concentrations of hsCRP, is associated with increased risk of atherosclerotic cardiovascular disease (21 ‐ 23) and endothelial dysfunction ( 23 ).”
Background
Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy
Fichtlscherer, S., Schmidt‐Lucke, C., Bojunga, S., Rössig, L., Heeschen, C., Dimmeler, S., & Zeiher, A. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi881 · Cited by 140
“At the time of the FBF study, blood samples were collected, and serum and plasma were aliquoted and stored at 2808C until analysed for the measurement of high-sensitive C-reactive protein (hs-C-reactive protein) using an ultrasensitive assay (N Latex C-reactive protein mono; Behring) as described.(6) Serum lipid level…”
MethodSelf-citation
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling
Singh, U. S., Devaraj, S., Vasquez-Vivar, J. M., & Jialal, I. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.015 · Cited by 141
Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight
Guven, M. A., Coşkun, A., Ertaş, İ. E., Aral, M., Zencirci, B., & Öksüz, H. (2009) · Hypertension in Pregnancy · doi:10.1080/10641950802601179 · Cited by 137
“84** Gravidity** 3 [1–10] 2.”
Effects of Systemic Inflammation on Endothelium-Dependent Vasodilation
Huang, A. L., & Vita, J. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.10.002 · Cited by 137
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Reference Study population Inflammatory marker Assessment of endothelial function Results coronary microcirculation Vita et al. (2004) 2701 Community-based subjects CRP, IL-6, MCP-1, and sICAM-1 Brachial artery FMD and reactive hyperem…”
Background
Endothelial dysfunction and inflammation—is there a link?
Stenvinkel, P. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.10.1968 · Cited by 136
The Endothelium and Inflammation
Trepels, T., Zeiher, A. M., & Fichtlscherer, S. (2006) · Endothelium · doi:10.1080/10623320601061862 · Cited by 138
Self-citation
Need to Test the Arterial Inflammation Hypothesis
Bhatt, D. L., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000021112.29409.a2 · Cited by 136
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
Hetzel, J., Balletshofer, B. M., Rittig, K., Walcher, D., Kratzer, W., Hombach, V., Häring, H., Köenig, W., & Marx, N. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000176192.16951.9a · Cited by 136
Forearm reactive hyperemia and mortality in end-stage renal disease
London, G. M., Pannier, B., Agharazii, M., Guérin, A. P., Verbeke, F., & Marchais, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00434.x · Cited by 134
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms
Schindler, T. H., Hornig, B., Buser, P. T., Olschewski, M., Magosaki, N., Pfisterer, M. E., Nitzsche, E. U., Solzbach, U., & Just, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057571.03012.f4 · Cited by 132
Inflammation and atherosclerosis in rheumatoid arthritis
Stevens, R. J., Douglas, K., Saratzis, A. N., & Kitas, G. D. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405009154 · Cited by 131
Physical Fitness and C-Reactive Protein Level in Children and Young Adults: The Columbia University BioMarkers Study
Isasi, C. R., Deckelbaum, R. J., Tracy, R. P., Starc, T. J., Berglund, L., & Shea, S. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.332 · Cited by 127
American Society of Echocardiography Report
Roman, M. J., Naqvi, T. Z., Gardin, J. M., Gerhard‐Herman, M. D., Jaff, M. R., & Mohler, E. R. (2006) · Vascular Medicine · doi:10.1177/1358863x06070511 · Cited by 129
Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide–Mediated Vasodilatation in Patients With Coronary Artery Disease
Fichtlscherer, S., Dimmeler, S., Breuer, S., Busse, R., Zeiher, A. M., & Fleming, I. (2003) · Circulation · doi:10.1161/01.cir.0000105763.51286.7f · Cited by 128
Self-citation

Authors: Fichtlscherer, S., Rosenberger, G., Walter, D. H., Breuer, S., Dimmeler, S., & Zeiher, A. M.
Affiliations: Goethe University Frankfurt (DE)
ORCID: Walter, Dirk H.
Dimmeler, Stefanie
Zeiher, Andreas M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-08-29
Volume: 102
Issue: 9
Pages: 1000-1006
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.102.9.1000
OpenAlex: W2076633296
Cited by: 665
References: 25
Citations by year: 2026: 3 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 17 · 2017: 16 · 2016: 18 · 2015: 18 · 2014: 26 · 2013: 27 · 2012: 21
FWCI: 23.45
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords: C-reactive protein, coronary artery disease, endothelial dysfunction, endothelium-dependent vasodilation, acetylcholine response, forearm blood flow, systemic inflammation, cardiovascular risk factors, atherosclerosis, sodium nitroprusside
MeSH terms: Acetylcholine, Adrenergic beta-Antagonists, Aspirin, Brachial Artery, C-Reactive Protein, Coronary Disease, Endothelium, Vascular, Follow-Up Studies, Forearm, Humans, Inflammation, Infusions, Intra-Arterial, Male, Middle Aged, Nitroprusside, Regional Blood Flow, Risk Factors, Vasodilation, Vasodilator Agents, Biomarkers, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks